| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 3 | |
| #2 | China | 2 | |
| #3 | Singapore | 2 | |
| #4 | Australia | 1 | |
| #5 | Canada | 1 | |
| #6 | EPO (European Patent Office) | 1 | |
| #7 | Republic of Korea | 1 | |
| #8 | Mexico | 1 | |
| #9 | Philippines | 1 | |
| #10 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Heterocyclic compounds | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Zhou Chao | 13 |
| #2 | Zheng Zhixiang | 11 |
| #3 | Kong Norman Xianglong | 8 |
| #4 | Kong Xianglong Norman | 4 |
| #5 | Chen Xiangyang | 2 |
| #6 | Chao Zhou | 1 |
| #7 | Norman Xianglong Kong | 1 |
| #8 | Zhixiang Zheng | 1 |
| #9 | Kong Xianglong | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2018228275A1 | Heterocyclic compound used as mnk inhibitor | |
| AU2017295628A1 | Heterocyclic compound used as FGFR inhibitor |